Advertisement

Clinical application of serum alpha-fetoprotein-IgM complexes on the diagnosis of primary hepatocellular carcinoma in Kazakh and Han populations

Abstract

Aims and background. We detected serum AFP-IgM levels in patients with primary hepatocellular carcinoma in Kazakh and Han populations to investigate the clinical significance of AFP-IgM in the diagnosis of hepatocellular carcinoma.
Methods and study design. Serum AFP-IgM levels were examined in 28 cases of hepatocellular carcinoma and 164 controls in the Kazakh population and in 85 cases of hepatocellular carcinoma and 187 controls in the Han population. AFP-IgM was detected with the ELISA assay.
Results. In general, serum AFP-IgM levels of hepatocellular carcinoma patients in the Han population and hepatocellular carcinoma patients in the Kazakh population were statistically higher than those of controls, but there was no statistical significance between hepatocellular carcinoma patients in the Han and hepatocellular carcinoma patients in the Kazakh population.
Conclusions. AFP-IgM is an encouraging serological marker and may be useful in the diagnosis of hepatocellular carcinoma.

Tumori 2013; 99(4): 535 - 539

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1361.15107

Authors

Jun Wu, Han Zou, Jing-Ting Jiang, Xiao-Dong Li, Xue-Mei Zhao, Ken Jar, Hong Wang, Bin Xu, Chang-Ping Wu

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Wu, Jun [PubMed] [Google Scholar]
    Department of Oncology, Third Affiliated Hospital of Soochow University, Changzhu, China
  • Zou, Han [PubMed] [Google Scholar]
    Kuntun Hospital of Ili Autonomous Prefecture, The Third Affiliated Hospital of Soochow University, Changzhu, China
  • Jiang, Jing-Ting [PubMed] [Google Scholar]
    Department of Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhu, China
  • Li, Xiao-Dong [PubMed] [Google Scholar]
    Department of Oncology, Third Affiliated Hospital of Soochow University, Changzhu, China
  • Zhao, Xue-Mei [PubMed] [Google Scholar]
    Kuntun Hospital of Ili Autonomous Prefecture, The Third Affiliated Hospital of Soochow University, Changzhu, China
  • Jar, Ken [PubMed] [Google Scholar]
    Kuntun Hospital of Ili Autonomous Prefecture, The Third Affiliated Hospital of Soochow University, Changzhu, China
  • Wang, Hong [PubMed] [Google Scholar]
    Kuntun Hospital of Ili Autonomous Prefecture, The Third Affiliated Hospital of Soochow University, Changzhu, China
  • Xu, Bin [PubMed] [Google Scholar]
    Department of Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhu, China
  • Wu, Chang-Ping [PubMed] [Google Scholar]
    Department of Oncology, Third Affiliated Hospital of Soochow University, Changzhu, China

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.